https://patentbrief.org/company/abbvie-biotechnology-ltd Plain-English explanations of patents assigned to AbbVie Biotechnology Ltd, newest first. en-us Mon, 15 Jun 2026 06:01:46 GMT https://patentbrief.org/patent/us/8889135/humira-biosimilar-barrier This patent defines the specific 40mg biweekly injection schedule for the drug Humira to treat rheumatoid arthritis. Tue, 18 Nov 2014 00:00:00 GMT https://patentbrief.org/patent/us/8889135/humira-biosimilar-barrier